NCT00679653 - Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives | Biotech Hunter

Enrollment

171

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

December 31, 2003

Conditions

ObesityHypertension

Interventions

DRUG

sibutramine

8-wks, sibutramine, 10 mg, capsules, once daily

DRUG

sibutramine

8-wks, sibutramine, 15 mg, capsules, once daily

DRUG

verapamil/trandolapril

2 wk Run-in phase, antihypertensive therapy only

DRUG

metoprolol/HCT

2 wk Run-in phase, antihypertensive therapy only

DRUG

felodipine/ramipril

2 wk Run-in phase, antihypertensive therapy only